Circulation, Vol 86, 100-110, Copyright © 1992 by American Heart Association
BACKGROUND. Cilazapril is a novel angiotensin converting enzyme inhibitor
with antiproliferative effects in the rat model after balloon injury.
METHODS AND RESULTS. We conducted a randomized, double-blind
placebo-controlled trial to assess the effect of cilazapril in angiographic
restenosis prevention after percutaneous transluminal coronary angioplasty
(PTCA). Patients received cilazapril 2.5 mg in the evening after successful
PTCA and 5 mg b.i.d. for 6 months or matched placebo. In addition, all
patients received aspirin for 6 months. Coronary angiograms before PTCA,
after PTCA, and at 6-month follow-up were quantitatively analyzed. In 94%
of 735 recruited patients, PTCA was successful and all inclusion and
exclusion criteria were met. For the per-protocol analysis, quantitative
angiography after PTCA and at follow-up was available in 595 patients who
complied with the treatment regimen (309 control, 286 cilazapril). The mean
difference in minimal coronary lumen diameter between post-PTCA and
follow-up angiogram (primary end point) was -0.29 +/- 0.49 mm in the
control group and - 0.27 +/- 0.51 mm in the cilazapril group. Clinical
events during 6- month follow-up, analyzed on an intention-to-treat basis,
were ranked according to the most serious clinical event ranging from death
(control, two; cilazapril, three), nonfatal myocardial infarction (control,
eight; cilazapril, 5), coronary revascularization (control, 51; cilazapril,
53), or recurrent angina requiring medical therapy (control, 67;
cilazapril, 68) to none of the above (control, 224; cilazapril, 212). There
were no significant differences in ranking. CONCLUSIONS. Long-term
angiotensin converting enzyme inhibition with cilazapril in a dose of 5 mg
b.i.d. does not prevent restenosis and does not favorably influence the
overall clinical outcome after PTCA.
ARTICLES
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group
This article has been cited by other articles:
 |
|
 |
|
  C. Schindler, A. Mueller, P. Bramlage, W. Boecking, W. Kirch, and J. Schweizer Comparison of Selective AT1-Receptor Blockade Versus ACE Inhibition for Restenosis Prophylaxis in Patients With Peripheral Occlusive Arterial Disease After Stent Angioplasty: A Randomized, Controlled, Proof-of-Concept Study Angiology, January 1, 2008; 58(6): 710 - 716. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Heeneman, J. C. Sluimer, and M. J.A.P. Daemen Angiotensin-Converting Enzyme and Vascular Remodeling Circ. Res., August 31, 2007; 101(5): 441 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Danchin, M. Cucherat, C. Thuillez, E. Durand, Z. Kadri, and P. G. Steg Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction: An Overview of Long-term Randomized Controlled Trials. Arch Intern Med, April 10, 2006; 166(7): 787 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M Franks and S. F Gardner AGI-1067: A Novel Vascular Protectant for Prevention of Restenosis Ann. Pharmacother., January 1, 2006; 40(1): 66 - 73. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Rakow, C. Vincent, K. Bull, and N. Harvey Assessing the Likelihood of an Important Clinical Outcome: New Insights from a Comparison of Clinical and Actuarial Judgment Med Decis Making, May 1, 2005; 25(3): 262 - 282. [Abstract] [PDF]
|
|
|
|
 |
|
 L. J Wagenaar, A. J van Boven, A. C van der Wal, G. Amoroso, R. A Tio, C. M van der Loos, A. E Becker, and W. H van Gilst Differential localisation of the renin-angiotensin system in de-novo lesions and in-stent restenotic lesions in in-vivo human coronary arteries Cardiovasc Res, October 1, 2003; 59(4): 980 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Keavney Outcome following percutaneous coronary intervention: not, so far, in our genes Heart, March 1, 2003; 89(3): 247 - 248. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takai, H. Sakonjo, K. Fukuda, D. Jin, M. Sakaguchi, K. Kamoshita, K. Ishida, Y. Sukenaga, and M. Miyazaki A Novel Chymase Inhibitor, 2-(5-Formylamino-6-oxo-2-phenyl-1,6-dihydropyrimidine-1-yl)-N-[{3,4-dioxo-1-phenyl-7-(2-pyridyloxy)}-2-heptyl]acetamide (NK3201), Suppressed Intimal Hyperplasia after Balloon Injury J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 841 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Derian, B. P. Damiano, M. F. Addo, A. L. Darrow, M. R. D'Andrea, M. Nedelman, H.-C. Zhang, B. E. Maryanoff, and P. Andrade-Gordon Blockade of the Thrombin Receptor Protease-Activated Receptor-1 with a Small-Molecule Antagonist Prevents Thrombus Formation and Vascular Occlusion in Nonhuman Primates J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 855 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chan Review: Developments in restenosis Journal of Renin-Angiotensin-Aldosterone System, September 1, 2002; 3(3): 145 - 149. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Tsunemi, S. Takai, M. Nishimoto, A. Yuda, D. Jin, M. Sakaguchi, Y. Sawada, K. Asada, K. Kondo, S. Sasaki, et al. Lengthy suppression of vascular proliferation by a chymase inhibitor in dog grafted veins J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 621 - 625. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim, Y. Izumi, Y. Izumiya, Y. Zhan, M. Taniguchi, and H. Iwao Beneficial Effects of Combined Blockade of ACE and AT1 Receptor on Intimal Hyperplasia in Balloon-Injured Rat Artery Arterioscler Thromb Vasc Biol, August 1, 2002; 22(8): 1299 - 1304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Indolfi, D. Torella, C. Coppola, E. Stabile, G. Esposito, A. Curcio, A. Pisani, L. Cavuto, O. Arcucci, M. Cireddu, et al. Rat carotid artery dilation by PTCA balloon catheter induces neointima formation in presence of IEL rupture Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H760 - H767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. P. Agema, J. W. Jukema, S. N. Pimstone, and J. J. P. Kastelein Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy Eur. Heart J., November 2, 2001; 22(22): 2058 - 2074. [PDF]
|
|
|
|
 |
|
 E. Jorgensen, H. Kelbaek, S. Helqvist, G. V. H. Jensen, K. Saunamaki, J. Kastrup, O. Havndrup, H. Bundgaard, J. Kyst Madsen, M. Christiansen, et al. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1434 - 1439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yau, D. P. Wilson, J. P. Werner, and P. Zahradka Bradykinin receptor antagonists attenuate neointimal proliferation postangioplasty Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1648 - H1656. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nishimoto, S. Takai, S. Kim, D. Jin, A. Yuda, M. Sakaguchi, M. Yamada, Y. Sawada, K. Kondo, K. Asada, et al. Significance of Chymase-Dependent Angiotensin II-Forming Pathway in the Development of Vascular Proliferation Circulation, September 11, 2001; 104(11): 1274 - 1279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mercado, E. Boersma, W. Wijns, B. J. Gersh, C. A. Morillo, V. de Valk, G.-A. van Es, D. E. Grobbee, and P. W. Serruys Clinical and quantitative coronary angiographic predictors of coronary restenosis: A comparative analysis from the balloon-to-stent era J. Am. Coll. Cardiol., September 1, 2001; 38(3): 645 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, J. T. Dove, A. K. Jacobs, J. Ward Kennedy, D. Kereiakes, M. J. Kern, R. E. Kuntz, J. J. Popma, H. V. Schaff, D. O. Williams, et al. ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions J. Am. Coll. Cardiol., June 15, 2001; 37(8): 2239 - 2239. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Rodriguez-Perez, F. Rodriguez-Esparragon, O. Hernandez-Perera, A. Anabitarte, A. Losada, A. Medina, E. Hernandez, D. Fiuza, O. Avalos, C. Yunis, et al. Association of angiotensinogen m235t and a(-6)g gene polymorphisms with coronary heart disease with independence of essential hypertension: the procagene study J. Am. Coll. Cardiol., May 1, 2001; 37(6): 1536 - 1542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.Y Salame, S Verheye, I.R Crocker, N.A.F Chronos, K.A Robinson, and S.B King III Intracoronary radiation therapy Eur. Heart J., April 2, 2001; 22(8): 629 - 647. [PDF]
|
|
|
|
 |
|
 R. Y. L. Zee, A. Fernandez-Ortiz, C. Macaya, E. Pintor, K. Lindpaintner, and A. Fernandez-Cruz ACE D/I Polymorphism and Incidence of Post-PTCA Restenosis : A Prospective, Angiography-Based Evaluation Hypertension, March 1, 2001; 37(3): 851 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hoshida, J. Kato, M. Nishino, Y. Egami, T. Takeda, M. Kawabata, J. Tanouchi, Y. Yamada, and T. Kamada Increased Angiotensin-Converting Enzyme Activity in Coronary Artery Specimens From Patients With Acute Coronary Syndrome Circulation, February 6, 2001; 103(5): 630 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takeuchi, F. X. McGowan Jr, A. M. Moran, D. Zurakowski, J. E. Mayer Jr, R. A. Jonas, and P. J. del Nido Surgical outcome of double-outlet right ventricle with subpulmonary VSD Ann. Thorac. Surg., January 1, 2001; 71(1): 49 - 53. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Wahl, M Billinger, M Fleisch, B Meier, and C Seiler Quantitatively assessed coronary collateral circulation and restenosis following percutaneous revascularization Eur. Heart J., November 1, 2000; 21(21): 1776 - 1784. [Abstract] [PDF]
|
|
|
|
|
|
M. Sabate, M. A. Costa, K. Kozuma, I. P. Kay, C. J. van der Wiel, V. Verin, W. Wijns, P. W. Serruys, and on behalf of the Dose Finding Study Group Methodological and clinical implications of the relocation of the minimal luminal diameter after intracoronary radiation therapy J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1536 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kageyama, H. Yamamoto, and R. Yoshimoto Anti-Human von Willebrand Factor Monoclonal Antibody AJvW-2 Prevents Thrombus Deposition and Neointima Formation After Balloon Injury in Guinea Pigs Arterioscler Thromb Vasc Biol, October 1, 2000; 20(10): 2303 - 2308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S Weinberg, A. J Weinberg, and D. H Zappe Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors Journal of Renin-Angiotensin-Aldosterone System, September 1, 2000; 1(3): 217 - 233. [PDF]
|
|
|
|
|
|
A G Violaris, A Thury, E Regar, R Melkert, and P W Serruys Influence of a history of smoking on short term (six month) clinical and angiographic outcome after successful coronary angioplasty Heart, September 1, 2000; 84(3): 299 - 306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. MacMahon, N. Sharpe, G. Gamble, A. Clague, C. Ni Mhurchu, T. Clark, H. Hart, J. Scott, H. White, and PART-2 Collaborative Research Group Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease J. Am. Coll. Cardiol., August 1, 2000; 36(2): 438 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Gottsauner-Wolf, G. Zasmeta, S. Hornykewycz, M. Nikfardjam, E. Stepan, P. Wexberg, G. Zorn, D. Glogar, P. Probst, G. Maurer, et al. Plasma levels of C-reactive protein after coronary stent implantation Eur. Heart J., July 2, 2000; 21(14): 1152 - 1158. [Abstract] [PDF]
|
|
|
|
|
|
P. W. Serruys, D. P. Foley, B. Hofling, J. Puel, H. D. Glogar, R. Seabra-Gomes, J. Goicolea, P. Coste, W. Rutsch, H. Katus, et al. Carvedilol for Prevention of Restenosis After Directional Coronary Atherectomy : Final Results of the European Carvedilol Atherectomy Restenosis (EUROCARE) Trial Circulation, April 4, 2000; 101(13): 1512 - 1518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Miyazaki and S. Takai Role of chymase on vascular proliferation Journal of Renin-Angiotensin-Aldosterone System, March 1, 2000; 1(1): 23 - 26. [PDF]
|
|
|
|
 |
|
 S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Holm, C. B. Andersen, S. Haunso, and P. Riis Hansen ACE-inhibition promotes apoptosis after balloon injury of rat carotid arteries Cardiovasc Res, February 1, 2000; 45(3): 777 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Wiegman, W. L. Barry, J. A. McPherson, C. A. McNamara, L. W. Gimple, J. M. Sanders, G. G. Bishop, E. R. Powers, M. Ragosta, G. K. Owens, et al. All-trans-Retinoic Acid Limits Restenosis After Balloon Angioplasty in the Focally Atherosclerotic Rabbit : A Favorable Effect on Vessel Remodeling Arterioscler Thromb Vasc Biol, January 1, 2000; 20(1): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Hollenberg Implications of Species Difference for Clinical Investigation : Studies on the Renin-Angiotensin System Hypertension, January 1, 2000; 35(1): 150 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lundell, A. B. Kelly, J. Anderson, M. Marijianowski, J. J. Rade, S. R. Hanson, and L. A. Harker Reduction in Vascular Lesion Formation by Hirudin Secreted From Retrovirus-Transduced Confluent Endothelial Cells on Vascular Grafts in Baboons Circulation, November 9, 1999; 100(19): 2018 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kleemann, S. Eckert, A. von Eckardstein, W. Lepper, U. Schernikau, U. Gleichmann, P. Hanrath, E. Fleck, A. Neiss, S. Kerber, et al. Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA. The Cholesterol Lowering Atherosclerosis PTCA Trial (CLAPT) Eur. Heart J., October 1, 1999; 20(19): 1393 - 1406. [Abstract] [PDF]
|
|
|
|
|
|
A. Okamura, M. Ohishi, H. Rakugi, T. Katsuya, Y. Yanagitani, S. Takiuchi, Y. Taniyama, K. Moriguchi, H. Ito, Y. Higashino, et al. Pharmacogenetic Analysis of the Effect of Angiotensin-Converting Enzyme Inhibitor on Restenosis After Percutaneous Transluminal Coronary Angioplasty Angiology, October 1, 1999; 50(10): 811 - 822. [Abstract] [PDF]
|
|
|
|
|
|
S. Takai, D. Jin, M. Sakaguchi, and M. Miyazaki Chymase-Dependent Angiotensin II Formation in Human Vascular Tissue Circulation, August 10, 1999; 100(6): 654 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sidiropoulos, J. Ritter, M. Schneider, and W. Konertz Fontan modification for subsequent non-surgical Fontan completion Eur. J. Cardiothorac. Surg., May 1, 1999; 13(5): 509 - 513. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Gallo, A. Padurean, T. Jayaraman, S. Marx, M. Roque, S. Adelman, J. Chesebro, J. Fallon, V. Fuster, A. Marks, et al. Inhibition of Intimal Thickening After Balloon Angioplasty in Porcine Coronary Arteries by Targeting Regulators of the Cell Cycle Circulation, April 27, 1999; 99(16): 2164 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Iaccarino, L. A. Smithwick, R. J. Lefkowitz, and W. J. Koch Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: A novel strategy to limit restenosis PNAS, March 30, 1999; 96(7): 3945 - 3950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Dollery, J. R. McEwan, M. Wang, Q. A. Sang, Y. E. Liu, and Y. E. Shi TIMP-4 Is Regulated by Vascular Injury in Rats Circ. Res., March 19, 1999; 84(5): 498 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shiota, H. Okunishi, S. Takai, I. Mikoshiba, H. Sakonjo, N. Shibata, and M. Miyazaki Tranilast Suppresses Vascular Chymase Expression and Neointima Formation in Balloon-Injured Dog Carotid Artery Circulation, March 2, 1999; 99(8): 1084 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Harada, I. Komuro, T. Sugaya, K. Murakami, and Y. Yazaki Vascular Injury Causes Neointimal Formation in Angiotensin II Type 1a Receptor Knockout Mice Circ. Res., February 5, 1999; 84(2): 179 - 185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.W. Serruys, D.P. Foley, G. Jackson, H. Bonnier, C. Macaya, M. Vrolix, A. Branzi, J. Shepherd, H. Suryapranata, P.J. de Feyter, et al. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty: Final results of the fluvastatin angiographic restenosis (FLARE) trial Eur. Heart J., January 1, 1999; 20(1): 58 - 69. [Abstract] [PDF]
|
|
|
|
|
|
X.-P. Xi, K. Graf, S. Goetze, E. Fleck, W. A. Hsueh, and R. E. Law Central Role of the MAPK Pathway in Ang II–Mediated DNA Synthesis and Migration in Rat Vascular Smooth Muscle Cells Arterioscler Thromb Vasc Biol, January 1, 1999; 19(1): 73 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yanagitani, H. Rakugi, A. Okamura, K. Moriguchi, S. Takiuchi, M. Ohishi, K. Suzuki, J. Higaki, and T. Ogihara Angiotensin II Type 1 Receptor–Mediated Peroxide Production in Human Macrophages Hypertension, January 1, 1999; 33(1): 335 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Labinaz, K. Pels, C. Hoffert, S. Aggarwal, and E. R O'Brien Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries Cardiovasc Res, January 1, 1999; 41(1): 255 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. K. Hollenberg, N. D. L. Fisher, and D. A. Price Pathways for Angiotensin II Generation in Intact Human Tissue : Evidence From Comparative Pharmacological Interruption of the Renin System Hypertension, September 1, 1998; 32(3): 387 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gershlick Endovascular manipulation to restrict restenosis Vascular Medicine, August 1, 1998; 3(3): 177 - 188. [Abstract] [PDF]
|
|
|
|
|
|
S. Chandra, L. V. Clark, R. W. Coatney, L. Phan, S. K. Sarkar, and E. H. Ohlstein Application of Serial In Vivo Magnetic Resonance Imaging to Evaluate the Efficacy of Endothelin Receptor Antagonist SB 217242 in the Rat Carotid Artery Model of Neointima Formation Circulation, June 9, 1998; 97(22): 2252 - 2258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Koyama and M. A. Reidy Expression of Extracellular Matrix Proteins Accompanies Lesion Growth in a Model of Intimal Reinjury Circ. Res., May 19, 1998; 82(9): 988 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Challah, E. Villard, M. Philippe, A. Ribadeau-Dumas, B. Giraudeau, P. Janiak, J.-P. Vilaine, F. Soubrier, and J.-B. Michel Angiotensin I-Converting Enzyme Genotype Influences Arterial Response to Injury in Normotensive Rats Arterioscler Thromb Vasc Biol, February 1, 1998; 18(2): 235 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Muller, W. Fischli, J.-P. Clozel, K. F. Hilgers, J. Bohlender, J. Menard, A. Busjahn, D. Ganten, and F. C. Luft Local Angiotensin II Generation in the Rat Heart : Role of Renin Uptake Circ. Res., January 23, 1998; 82(1): 13 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ribichini, G. Steffenino, A. Dellavalle, G. Matullo, E. Colajanni, T. Camilla, A. Vado, G. Benetton, E. Uslenghi, and A. Piazza Plasma Activity and Insertion/Deletion Polymorphism of Angiotensin I–Converting Enzyme : A Major Risk Factor and a Marker of Risk for Coronary Stent Restenosis Circulation, January 20, 1998; 97(2): 147 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ohishi, M. Ueda, H. Rakugi, A. Okamura, T. Naruko, A. E. Becker, K. Hiwada, A. Kamitani, K. Kamide, J. Higaki, et al. Upregulation of Angiotensin-Converting Enzyme During the Healing Process After Injury at the Site of Percutaneous Transluminal Coronary Angioplasty in Humans Circulation, November 18, 1997; 96(10): 3328 - 3337. [Abstract] [Full Text]
|
|
|
|
|
|
R. D. Kenagy, C. E. Hart, W. G. Stetler-Stevenson, and A. W. Clowes Primate Smooth Muscle Cell Migration From Aortic Explants Is Mediated by Endogenous Platelet-Derived Growth Factor and Basic Fibroblast Growth Factor Acting Through Matrix Metalloproteinases 2 and 9 Circulation, November 18, 1997; 96(10): 3555 - 3560. [Abstract] [Full Text]
|
|
|
|
|
|
J. Wong, C. Rauhoft, R. J. Dilley, A. Agrotis, G. L. Jennings, and A. Bobik Angiotensin-Converting Enzyme Inhibition Abolishes Medial Smooth Muscle PDGF-AB Biosynthesis and Attenuates Cell Proliferation in Injured Carotid Arteries : Relationships to Neointima Formation Circulation, September 2, 1997; 96(5): 1631 - 1640. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. J. Topol, J. J. Ferguson, H. F. Weisman, J. E. Tcheng, S. G. Ellis, N. S. Kleiman, R. J. Ivanhoe, A. L. Wang, D. P. Miller, K. M. Anderson, et al. Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin {beta}3 Blockade With Percutaneous Coronary Intervention JAMA, August 13, 1997; 278(6): 479 - 484. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Fernandez-Alfonso, P. A. Martorana, I. Licka, P. van Even, D. Trobisch, B. A. Scholkens, and M. Paul Early Induction of Angiotensin I–Converting Enzyme in Rat Carotid Artery After Balloon Injury Hypertension, August 1, 1997; 30(2): 272 - 277. [Abstract] [Full Text]
|
|
|
|
|
|
T. C. Koutlas, J. W. Gaynor, S. C. Nicolson, J. M. Steven, G. Wernovsky, and T. L. Spray Modified Ultrafiltration Reduces Postoperative Morbidity After Cavopulmonary Connection Ann. Thorac. Surg., July 1, 1997; 64(1): 37 - 42. [Abstract] [Full Text]
|
|
|
|
|
|
C. Amant, C. Bauters, J.-C. Bodart, J.-M. Lablanche, G. Grollier, N. Danchin, M. Hamon, F. Richard, N. Helbecque, E. P. McFadden, et al. D Allele of the Angiotensin I–Converting Enzyme Is a Major Risk Factor for Restenosis After Coronary Stenting Circulation, July 1, 1997; 96(1): 56 - 60. [Abstract] [Full Text]
|
|
|
|
|
|
G. W. Stone, J. M. Hodgson, F. G. St Goar, A. Frey, H. Mudra, H. Sheehan, and T. J. Linnemeier Improved Procedural Results of Coronary Angioplasty With Intravascular Ultrasound–Guided Balloon Sizing : The CLOUT Pilot Trial Circulation, April 15, 1997; 95(8): 2044 - 2052. [Abstract] [Full Text]
|
|
|
|
|
|
V. Verin, P. Urban, Y. Popowski, M. Schwager, P. Nouet, P. A. Dorsaz, P. Chatelain, J. M. Kurtz, and W. Rutishauser Feasibility of Intracoronary ß-Irradiation to Reduce Restenosis After Balloon Angioplasty: A Clinical Pilot Study Circulation, March 4, 1997; 95(5): 1138 - 1144. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. Crossman Science, medicine, and the future: The future of the management of ischaemic heart disease BMJ, February 1, 1997; 314(7077): 356 - 356. [Abstract] [Full Text]
|
|
|
|
|
|
R.D. Kenagy, S. Vergel, E. Mattsson, M. Bendeck, M.A. Reidy, and A.W. Clowes The Role of Plasminogen, Plasminogen Activators, and Matrix Metalloproteinases in Primate Arterial Smooth Muscle Cell Migration Arterioscler Thromb Vasc Biol, November 1, 1996; 16(11): 1373 - 1382. [Abstract] [Full Text]
|
|
|
|
|
|
C. Chen, S. G. Mattar, J. D. Hughes, G. F. Pierce, J. E. Cook, D. N. Ku, S. R. Hanson, and A. B. Lumsden Recombinant Mitotoxin Basic Fibroblast Growth Factor–Saporin Reduces Venous Anastomotic Intimal Hyperplasia in the Arteriovenous Graft Circulation, October 15, 1996; 94(8): 1989 - 1995. [Abstract] [Full Text]
|
|
|
|
|
|
C. Gerdes, V. Faber-Steinfeld, O. Yalkinoglu, and S. Wohlfeil Comparison of the Effects of the Thrombin Inhibitor r-Hirudin in Four Animal Models of Neointima Formation After Arterial Injury Arterioscler Thromb Vasc Biol, October 1, 1996; 16(10): 1306 - 1311. [Abstract] [Full Text]
|
|
|
|
|
|
F. H. Messerli, M. A. Weber, and H. R. Brunner Angiotensin II Receptor Inhibition: A New Therapeutic Principle Arch Intern Med, September 23, 1996; 156(17): 1957 - 1965. [Abstract] [PDF]
|
|
|
|
|
|
L. A. Guzman, V. Labhasetwar, C. Song, Y. Jang, A. M. Lincoff, R. Levy, and E. J. Topol Local Intraluminal Infusion of Biodegradable Polymeric Nanoparticles: A Novel Approach for Prolonged Drug Delivery After Balloon Angioplasty Circulation, September 15, 1996; 94(6): 1441 - 1448. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. A. Golden Intimal Hyperplasia: Prospects for Its Control in the Human Vascular and Endovascular Surgery, September 1, 1996; 30(5): 361 - 364. [PDF]
|
|
|
|
|
|
E. M. van Kleef, J. Fingerle, and M. J.A.P. Daemen Angiotensin II-Induced Progression of Neointimal Thickening in the Balloon-Injured Rat Carotid Artery Is AT1 Receptor Mediated Arterioscler Thromb Vasc Biol, July 1, 1996; 16(7): 857 - 863. [Abstract] [Full Text]
|
|
|
|
|
|
N. A. Scott, G. D. Cipolla, C. E. Ross, B. Dunn, F. H. Martin, L. Simonet, and J. N. Wilcox Identification of a Potential Role for the Adventitia in Vascular Lesion Formation After Balloon Overstretch Injury of Porcine Coronary Arteries Circulation, June 15, 1996; 93(12): 2178 - 2187. [Abstract] [Full Text]
|
|
|
|
|
|
S. B. King III Angioplasty From Bench to Bedside to Bench Circulation, May 1, 1996; 93(9): 1621 - 1629. [Full Text]
|
|
|
|
|
|
A. D. Hamdan, W. C. Quist, J. B. Gagne, and E. P. Feener Angiotensin-Converting Enzyme Inhibition Suppresses Plasminogen Activator Inhibitor-1 Expression in the Neointima of Balloon-Injured Rat Aorta Circulation, March 15, 1996; 93(6): 1073 - 1078. [Abstract] [Full Text]
|
|
|
|
|
|
K. G. Lehmann, R. Melkert, and P. W. Serruys Contributions of Frequency Distribution Analysis to the Understanding of Coronary Restenosis : A Reappraisal of the Gaussian Curve Circulation, March 15, 1996; 93(6): 1123 - 1132. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Guzman, M. J. Mick, A. M. Arnold, F. Forudi, and P. L. Whitlow Role of Intimal Hyperplasia and Arterial Remodeling After Balloon Angioplasty : An Experimental Study in the Atherosclerotic Rabbit Model Arterioscler Thromb Vasc Biol, March 1, 1996; 16(3): 479 - 487. [Abstract] [Full Text]
|
|
|
|
|
|
R. E. Pratt and V. J. Dzau Pharmacological Strategies to Prevent Restenosis : Lessons Learned From Blockade of the Renin-Angiotensin System Circulation, March 1, 1996; 93(5): 848 - 852. [Full Text]
|
|
|
|
|
|
A. G. Violaris, R. Melkert, J.-P. R. Herrman, and P. W. Serruys Role of Angiographically Identifiable Thrombus on Long-term Luminal Renarrowing After Coronary Angioplasty : A Quantitative Angiographic Analysis Circulation, March 1, 1996; 93(5): 889 - 897. [Abstract] [Full Text]
|
|
|
|
|
|
W. R. Huckle, M. D. Drag, W. R. Acker, M. Powers, R. C. McFall, D. J. Holder, T. Fujita, I. I. Stabilito, D. Kim, D. L. Ondeyka, et al. Effects of Subtype-Selective and Balanced Angiotensin II Receptor Antagonists in a Porcine Coronary Artery Model of Vascular Restenosis Circulation, March 1, 1996; 93(5): 1009 - 1019. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Furukawa, A. Matsumori, T. Hirozane, and S. Sasayama Angiotensin II Receptor Antagonist TCV-116 Reduces Graft Coronary Artery Disease and Preserves Graft Status in a Murine Model : A Comparative Study With Captopril Circulation, January 15, 1996; 93(2): 333 - 339. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Geary, J. K. Williams, D. Golden, D. G. Brown, M. E. Benjamin, and M. R. Adams Time Course of Cellular Proliferation, Intimal Hyperplasia, and Remodeling Following Angioplasty in Monkeys With Established Atherosclerosis : A Nonhuman Primate Model of Restenosis Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 34 - 43. [Abstract] [Full Text]
|
|
|
|
|
|
J. Fingerle, R. M.K. Muller, H. Kuhn, M. Pech, and H. R. Baumgartner Mechanism of Inhibition of Neointimal Formation by the Angiotensin-Converting Enzyme Inhibitor Cilazapril : A Study in Balloon Catheter–Injured Rat Carotid Arteries Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1945 - 1950. [Abstract] [Full Text]
|
|
|
|
|
|
F. M. van Bockxmeer, C. D. S. Mamotte, F. A. Gibbons, V. Burke, and R. R. Taylor Angiotensin-Converting Enzyme and Apolipoprotein E Genotypes and Restenosis After Coronary Angioplasty Circulation, October 15, 1995; 92(8): 2066 - 2071. [Abstract] [Full Text]
|
|
|
|
|
|
S. M. Schwartz, D. deBlois, and E. R. M. O'Brien The Intima : Soil for Atherosclerosis and Restenosis Circ. Res., September 1, 1995; 77(3): 445 - 465. [Full Text]
|
|
|
|
|
|
R. Schmitt, J.-P. Clozel, N. Iberg, and F. R. Buhler Mibefradil Prevents Neointima Formation After Vascular Injury in Rats : Possible Role of the Blockade of the T-Type Voltage-Operated Calcium Channel Arterioscler Thromb Vasc Biol, August 1, 1995; 15(8): 1161 - 1165. [Abstract] [Full Text]
|
|
|
|
|
|
M. Hamon, C. Bauters, C. Amant, E. P. McFadden, N. Helbecque, J.-M. Lablanche, M. E. Bertrand, and P. Amouyel Relation Between the Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Late Luminal Narrowing After Coronary Angioplasty Circulation, August 1, 1995; 92(3): 296 - 299. [Abstract] [Full Text]
|
|
|
|
|
|
B. H. Strauss, M. K. Natarajan, W. B. Batchelor, D. E. Yardley, J. A. Bittl, T. A. Sanborn, J. A. Power, L. E. Watson, R. Moothart, J. E. Tcheng, et al. Early and Late Quantitative Angiographic Results of Vein Graft Lesions Treated by Excimer Laser With Adjunctive Balloon Angioplasty Circulation, August 1, 1995; 92(3): 348 - 356. [Abstract] [Full Text]
|
|
|
|
|
|
S. Kim, M. Kawamura, H. Wanibuchi, K. Ohta, A. Hamaguchi, T. Omura, T. Yukimura, K. Miura, and H. Iwao Angiotensin II Type 1 Receptor Blockade Inhibits the Expression of Immediate-Early Genes and Fibronectin in Rat Injured Artery Circulation, July 1, 1995; 92(1): 88 - 95. [Abstract] [Full Text]
|
|
|
|
|
|
R. L. Geary, N. Koyama, T. W. Wang, S. Vergel, and A. W. Clowes Failure of Heparin to Inhibit Intimal Hyperplasia in Injured Baboon Arteries : The Role of Heparin-Sensitive and -Insensitive Pathways in the Stimulation of Smooth Muscle Cell Migration and Proliferation Circulation, June 15, 1995; 91(12): 2972 - 2981. [Abstract] [Full Text]
|
|
|
|
|
|
C. Rogers and E. R. Edelman Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis Circulation, June 15, 1995; 91(12): 2995 - 3001. [Abstract] [Full Text]
|
|
|
|
|
|
A. Kamitani, H. Rakugi, J. Higaki, M. Ohishi, S.-J. Shi, S. Takami, Y. Nakata, Y. Higashino, K. Fujii, H. Mikami, et al. Enhanced Predictability of Myocardial Infarction in Japanese by Combined Genotype Analysis Hypertension, May 1, 1995; 25(5): 950 - 953. [Abstract] [Full Text]
|
|
|
|
|
|
A. G. Violaris, R. Melkert, and P. W. Serruys Long-term Luminal Renarrowing After Successful Elective Coronary Angioplasty of Total Occlusions : A Quantitative Angiographic Analysis Circulation, April 15, 1995; 91(8): 2140 - 2150. [Abstract] [Full Text]
|
|
|
|
|
|
D. Keane, J. Haase, C. J. Slager, E. M. van Swijndregt, K. G. Lehmann, Y. Ozaki, C. di Mario, R. Kirkeeide, and P. W. Serruys Comparative Validation of Quantitative Coronary Angiography Systems : Results and Implications From a Multicenter Study Using a Standardized Approach Circulation, April 15, 1995; 91(8): 2174 - 2183. [Abstract] [Full Text]
|
|
|
|
|
|
M. J.A.P. Daemen and J. G.R. De Mey Regional Heterogeneity of Arterial Structural Changes Hypertension, April 1, 1995; 25(4): 464 - 473. [Abstract] [Full Text]
|
|
|
|
|
|
C. Bauters, P. Khanoyan, E. P. Mc Fadden, P. Quandalle, J.-M. Lablanche, and M. E. Bertrand Restenosis After Delayed Coronary Angioplasty of the Culprit Vessel in Patients With a Recent Myocardial Infarction Treated by Thrombolysis Circulation, March 1, 1995; 91(5): 1410 - 1418. [Abstract] [Full Text]
|
|
|
|
|
|
P. de Groote, C. Bauters, E. P. McFadden, J.-M. Lablanche, F. Leroy, and M. E. Bertrand Local Lesion-Related Factors and Restenosis After Coronary Angioplasty : Evidence From a Quantitative Angiographic Study in Patients With Unstable Angina Undergoing Double-Vessel Angioplasty Circulation, February 15, 1995; 91(4): 968 - 972. [Abstract] [Full Text]
|
|